News on Tranzyme Pharma Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated Tranzyme Pharma Inc. news from BioPortfolio.com Wed, 10 Feb 2010 04:50:05 GMT en Tranzyme Pharma Announces Approval of Generic Name 'Ulimorelin' for TZP-101, its First-in-Class Drug Candidatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029574&HITNO=0&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029574&THISHREF=http://c.moreover.com/click/here.pl%3fz2533192094%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029574&HITNO=0&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029574&THISHREF=http://c.moreover.com/click/here.pl%3fz2533192094%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Tranzyme Pharma Inc.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014796&HITNO=1&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014796&THISHREF=http://c.moreover.com/click/here.pl%3fz2524163859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014796&HITNO=1&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014796&THISHREF=http://c.moreover.com/click/here.pl%3fz2524163859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Tranzyme Pharma Announces Approval of Generic Name EURUlimorelinEUR for TZP-101, its First-in-Class Drug Cahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986568&HITNO=2&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986568&THISHREF=http://c.moreover.com/click/here.pl%3fz2509255680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986568&HITNO=2&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986568&THISHREF=http://c.moreover.com/click/here.pl%3fz2509255680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Tranzyme Pharma Announces Approval Of Generic Name 'Ulimorelin' For TZP-101, Its First-in-Class Drug Candidatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3973188&HITNO=3&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3973188&THISHREF=http://c.moreover.com/click/here.pl%3fz2502791117%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3973188&HITNO=3&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3973188&THISHREF=http://c.moreover.com/click/here.pl%3fz2502791117%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: Medical News: Tranzyme Pharma Announces Approval Of Generic Name "Ulimorelin" For TZP-101, Its First-in-Class Drug Candidate For The Treatment Of GI Dysmotilityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972831&HITNO=4&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972831&THISHREF=http://c.moreover.com/click/here.pl%3fz2502628857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972831&HITNO=4&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972831&THISHREF=http://c.moreover.com/click/here.pl%3fz2502628857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Tranzyme Pharma Announces Approval of Generic Name Ulimorelin for TZP-101, its First-in-Class Drug Candidhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969018&HITNO=5&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969018&THISHREF=http://c.moreover.com/click/here.pl%3fz2500647530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969018&HITNO=5&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969018&THISHREF=http://c.moreover.com/click/here.pl%3fz2500647530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Tranzyme Pharma Announces Approval of Generic Name "Ulimorelin" for TZP-101, its First-in-Class Drug Candidate for thehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968348&HITNO=6&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968348&THISHREF=http://c.moreover.com/click/here.pl%3fz2500316590%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968348&HITNO=6&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968348&THISHREF=http://c.moreover.com/click/here.pl%3fz2500316590%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Tranzyme Pharma Announces Approval of Generic Name Ulimorelin for TZP-101, its First-in-Class Drug Candidate fhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968370&HITNO=7&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968370&THISHREF=http://c.moreover.com/click/here.pl%3fz2500333002%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968370&HITNO=7&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968370&THISHREF=http://c.moreover.com/click/here.pl%3fz2500333002%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobe Investor: Tranzyme Pharma Announces Approval of Generic Name 'Ulimorelin' for TZP-101, its First-in-Classhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968420&HITNO=8&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968420&THISHREF=http://c.moreover.com/click/here.pl%3fz2500363961%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968420&HITNO=8&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968420&THISHREF=http://c.moreover.com/click/here.pl%3fz2500363961%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: Tranzyme Pharma Announces Approval of Generic Name "Ulimorelin" for TZP-101, its First-in-Class Drug Candidate for the Treatment of Gastrointestinal Dysmotilityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968353&HITNO=9&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968353&THISHREF=http://c.moreover.com/click/here.pl%3fz2500318418%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968353&HITNO=9&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968353&THISHREF=http://c.moreover.com/click/here.pl%3fz2500318418%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Tranzyme Pharma Announces Approval of Generic Name 'Ulimorelin' for TZP-101, its First-in-Class Drug Candidatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968341&HITNO=10&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968341&THISHREF=http://c.moreover.com/click/here.pl%3fz2500311192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968341&HITNO=10&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968341&THISHREF=http://c.moreover.com/click/here.pl%3fz2500311192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Tranzyme Pharma Announces Approval of Generic Name 'Ulimorelin' for TZP-101, its First-in-Class Drug Candidatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968426&HITNO=11&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968426&THISHREF=http://c.moreover.com/click/here.pl%3fz2500367579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968426&HITNO=11&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968426&THISHREF=http://c.moreover.com/click/here.pl%3fz2500367579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Tranzyme Pharma Announces Approval of Generic Name Ulimorelin? for TZP-101, its First-in-Class Drug Candidatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970718&HITNO=12&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970718&THISHREF=http://c.moreover.com/click/here.pl%3fz2501462836%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970718&HITNO=12&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970718&THISHREF=http://c.moreover.com/click/here.pl%3fz2501462836%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Tranzyme Pharma Announces Approval of Generic Name Ulimorelin for TZP-101, its First-in-Class Drug Candidhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968515&HITNO=13&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968515&THISHREF=http://c.moreover.com/click/here.pl%3fz2500409167%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968515&HITNO=13&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968515&THISHREF=http://c.moreover.com/click/here.pl%3fz2500409167%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Tranzyme Pharma Announces Approval of Generic Name Ulimorelin for TZP-101, its First-in-Class Drug Candidate for the Treatment of Gastrointestinal Dysmotilityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968438&HITNO=14&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968438&THISHREF=http://c.moreover.com/click/here.pl%3fz2500378985%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968438&HITNO=14&MSIZE=35&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tranzyme%20Pharma%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968438&THISHREF=http://c.moreover.com/click/here.pl%3fz2500378985%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCentre Daily Times: